Bli medlem
Bli medlem

Du är här

2016-06-03

Getinge Group: Getinge Group appoints Jens Viebke as new President of Acute Care Therapies Business Category Unit

Press releaseGothenburg, June 3, 2016

Getinge Group has appointed Jens Viebke as the new President of the
Acute Care Therapies Business Category Unit. Jens will be a member of
the Getinge Group Executive Team and succeeds Heinz Jacqui who will
step down from his current position after four years with the Group.
Acute Care Therapies is one of Getinge's three Business Category
Units and is responsible for developing technologies and solutions
for cardiac, pulmonary and vascular therapies and products and
therapies for intensive care.

The Group has made significant investments in quality management
systems in recent years, particularly in areas related to the Acute
Care Therapies Business Category Unit. Intense focus continues to be
directed to completing the necessary improvement measures for
building up a global quality management system with the desired
standard.

The product segments in Acute Care Therapies, where Getinge has a
strong pipeline of new products, have significant growth potential
and investments continue to be made in developing pioneering
technologies and solutions.

"I am very pleased to present Jens Viebke as the new President of our
Acute Care Therapies Business Category Unit. We have faced a number
of challenges related to this product area in recent years and I have
every confidence in Jens using his extensive experience and expertise
to lead the operations in the right direction. With his comprehensive
knowledge in the field of research and development, coupled with his
commercial experience, Jens will be a major asset for the Group in
his new role," says Alex Myers, CEO and President of Getinge, who
concludes: "I would also like to take this opportunity to thank Heinz
Jacqui for his valuable contribution and dedicated work during his
time with the Group."

Jens Viebke most recently served as Chief Technology Officer at Acute
Care Therapies and was previously the President of the Critical Care
division in the Group's former Medical Systems business area. Jens
has long and broad experience from the healthcare industry and has
previously held positions in research and development, as well as
strategy and marketing, at other large companies in the industry,
including GE Healthcare and Pharmacia & Upjohn. Jens has a PhD in
Polymer Technology from the Royal Institute of Technology of
Stockholm and holds an Executive MBA from the Stockholm School of
Economics.

Jens Viebke will take up his new position as of June 6, 2016, and will
report to Alex Myers, President & CEO Getinge Group.

For more information, please contact:

Alex Myers
CEO and President, Getinge Group
Tel: +46 10 335 00 00
E-mail: alex.myers@getinge.com

Kornelia Rasmussen
Executive Vice President, Corporate Communications & Brand Management
Tel: +46 10 335 5810
E-mail: kornelia.rasmussen@getinge.com

Getinge Group is a leading global provider of innovative solutions for
operating rooms, intensive-care units, hospital wards, sterilization
departments, elderly care and for life science companies and
institutions. Getinge's unique customer offering mirrors the
hospital's organization and value chain, and the solutions are used
before, during and after the patients' hospital stay. Based on
first-hand experience and close partnerships, Getinge provides
innovative healthcare solutions that improve every-day life for
people, today and tomorrow.

This information is such that Getinge AB must disclose in accordance
with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act.

-----------------------------------------------------------
http://news.cision.com/getinge-group/r/getinge-group-appoints-jens-viebk...
http://mb.cision.com/Main/942/2022910/524613.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.